High Flow Nasal Oxygen and Acute Left Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 123 participants.
Also called NCT03607357
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 123 participants
- Sponsor
- Registry
-
NCT03607357
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03607357. Randomized; no masking; primary purpose treatment. Start 2018-05-10 (actual); primary completion 2021-05-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High Flow Nasal Oxygen and Acute Left Heart Failure
- Acronym
- HFNO
- Condition
- Heart Failure
- Condition
- Noninvasive Ventilation
- Condition
- Oxygen Therapy
- Intervention (Device)
- High Flow Nasal Oxygen
- Intervention (Device)
- Non-invasive Ventilation
- Lead sponsor
- Nanjing Jiangbei People's Hospital
- Collaborator
- Jiangsu Provincial People's Hospital
- Collaborator
- Jiangsu Province Hospital of Traditional Chinese Medicine
- Collaborator
- NanJing PLA 81 Hospital
- Collaborator
- Nanjing Chest Hospital
- Collaborator
- Mingji Hospital
- Collaborator
- Meishan Traditional Chinese Medicine Hospital
- Collaborator
- Nanjing LuHe People's Hospital
- Collaborator
- Nanjing Pukou Center Hospital
- Collaborator
- Thank Inn Chain Hotel Jiangsu Nanjing Lishui People's Hospital
- Collaborator
- Nanjing Gaochun People's Hospital
- Collaborator
- The First Affiliated Hospital with Nanjing Medical University
Record details
- Record id
cardio:ct-nct03607357- Content hash
ceea1821f184b03b216a715f6374a1be171450bd547dad2144b4f5384fac3e5a